| 1 | seen | 15,700 |
| 2 | arised | 9 |
| 3 | coinfused | 8 |
| 4 | postpolymerized | 3 |
| 5 | well-represented | 3 |
| 6 | effectiveless | 2 |
| 7 | good-excellent | 2 |
| 8 | immunoexpressed | 2 |
| 9 | morcellated | 2 |
| 10 | -0.05+/-0.41 | 1 |
| 11 | -12/+4 | 1 |
| 12 | -17.76 | 1 |
| 13 | -29.36+/-3.68mv | 1 |
| 14 | -5.1±5.6 | 1 |
| 15 | -8.3±1.0 | 1 |
| 16 | .1/1000 | 1 |
| 17 | 0.008μm | 1 |
| 18 | 0.150ng/ml | 1 |
| 19 | 0.23±0.22 | 1 |
| 20 | 0.29±0.26 | 1 |
| 21 | 0.42±0.99 | 1 |
| 22 | 0.49-1.73 | 1 |
| 23 | 0.56°c | 1 |
| 24 | 0.69+/-0.13 | 1 |
| 25 | 0.703+/-0.06 | 1 |
| 26 | 0.71μg/kg/hr | 1 |
| 27 | 0.726-/+0.061 | 1 |
| 28 | 1.10+/-0.87 | 1 |
| 29 | 1.1±1 | 1 |
| 30 | 1.3±3.15 | 1 |
| 31 | 1.4g/l | 1 |
| 32 | 1.50±0.81 | 1 |
| 33 | 1.52±0.7 | 1 |
| 34 | 1.72±1.34 | 1 |
| 35 | 1.7±1.53u | 1 |
| 36 | 1.8±1.3 | 1 |
| 37 | 1/1475 | 1 |
| 38 | 10+/-0 | 1 |
| 39 | 10.3±5.2 | 1 |
| 40 | 10.6° | 1 |
| 41 | 10.7months | 1 |
| 42 | 100:55 | 1 |
| 43 | 11.2±3.1 | 1 |
| 44 | 11.6+/-17 | 1 |
| 45 | 11.6° | 1 |
| 46 | 112.55° | 1 |
| 47 | 12+/-2.5 | 1 |
| 48 | 12.3+/-12.4 | 1 |
| 49 | 123.56+/-4.8 | 1 |
| 50 | 123° | 1 |
| 51 | 126.0months | 1 |
| 52 | 126.3° | 1 |
| 53 | 139.9±92 | 1 |
| 54 | 15-ketopge1 | 1 |
| 55 | 15.67±2.3 | 1 |
| 56 | 15.7±9 | 1 |
| 57 | 1596+/-362 | 1 |
| 58 | 16+/-7 | 1 |
| 59 | 16.4+/-7 | 1 |
| 60 | 166.1±65.49ml | 1 |
| 61 | 166/100,000 | 1 |
| 62 | 18:17 | 1 |
| 63 | 1:0.79 | 1 |
| 64 | 1:19,939 | 1 |
| 65 | 2.27±0.84mm | 1 |
| 66 | 2.2±1.4 | 1 |
| 67 | 2.38/10 | 1 |
| 68 | 2.44±0.88 | 1 |
| 69 | 2.54±2.34 | 1 |
| 70 | 2.72:1 | 1 |
| 71 | 2.95g/kg | 1 |
| 72 | 21.4s | 1 |
| 73 | 21.6232 | 1 |
| 74 | 216s | 1 |
| 75 | 22.26° | 1 |
| 76 | 230.57/1000 | 1 |
| 77 | 24/1000 | 1 |
| 78 | 27.5/59.1 | 1 |
| 79 | 27.56±4.20 | 1 |
| 80 | 2778.5 | 1 |
| 81 | 28-29°c | 1 |
| 82 | 29.2/28.7 | 1 |
| 83 | 29.2mg/day | 1 |
| 84 | 3.09±1.12 | 1 |
| 85 | 3.10±0.16 | 1 |
| 86 | 3.3±2.0 | 1 |
| 87 | 3.5±1.4msv | 1 |
| 88 | 3.75d | 1 |
| 89 | 30.32+/-25.97 | 1 |
| 90 | 322.5 | 1 |
| 91 | 33.6±11.9 | 1 |
| 92 | 34.68±30.75min | 1 |
| 93 | 36.7° | 1 |
| 94 | 3638rmb | 1 |
| 95 | 39,960 | 1 |
| 96 | 39.3/76.6 | 1 |
| 97 | 4.0/1,000 | 1 |
| 98 | 4.17+/-2.03 | 1 |
| 99 | 4.40mg/g | 1 |
| 100 | 4.90±2.07 | 1 |
| 101 | 40.7±8 | 1 |
| 102 | 42.9+/-2.8 | 1 |
| 103 | 43.9° | 1 |
| 104 | 4±3 | 1 |
| 105 | 5,453,441 | 1 |
| 106 | 5,588 | 1 |
| 107 | 5.0days | 1 |
| 108 | 5.1±1.88 | 1 |
| 109 | 5.58° | 1 |
| 110 | 5.8_0.26 | 1 |
| 111 | 5.9±2.2 | 1 |
| 112 | 530.83±43.48 | 1 |
| 113 | 590±506ng/ml | 1 |
| 114 | 6.1±10.98 | 1 |
| 115 | 6.72±0.99 | 1 |
| 116 | 63.4±7.8 | 1 |
| 117 | 75.6±11.0 | 1 |
| 118 | 78.3/228.3 | 1 |
| 119 | 8.05±0.43 | 1 |
| 120 | 8.07g/dl | 1 |
| 121 | 8.4+/-2.3 | 1 |
| 122 | 8.7/10 | 1 |
| 123 | 80.7° | 1 |
| 124 | 84.000 | 1 |
| 125 | 84.75+/-10.2 | 1 |
| 126 | 84.8±45.6 | 1 |
| 127 | 9.64min | 1 |
| 128 | 9.8/1000 | 1 |
| 129 | 91.4±27.7s | 1 |
| 130 | 92days | 1 |
| 131 | 95/100,000 | 1 |
| 132 | 98.6±9.8s | 1 |
| 133 | 99+/-22 | 1 |
| 134 | accomrease | 1 |
| 135 | achieved/maintained | 1 |
| 136 | added/intensified | 1 |
| 137 | administerd | 1 |
| 138 | antero-superior | 1 |
| 139 | applied.rebleeding | 1 |
| 140 | colo-vesical | 1 |
| 141 | comducted | 1 |
| 142 | corticosteroid-insensitive | 1 |
| 143 | cost-additive | 1 |
| 144 | d=0.416 | 1 |
| 145 | decarboxylized | 1 |
| 146 | deorphanized | 1 |
| 147 | diagnosticated | 1 |
| 148 | disscused | 1 |
| 149 | embolised | 1 |
| 150 | erradicated | 1 |
| 151 | evlauated | 1 |
| 152 | gastro-enteropancreatic | 1 |
| 153 | goserelin.for | 1 |
| 154 | grade≤3 | 1 |
| 155 | hpa-1a | 1 |
| 156 | humoral-pathological | 1 |
| 157 | hyperexpressed | 1 |
| 158 | hyposynchronization | 1 |
| 159 | indefinable | 1 |
| 160 | inproved | 1 |
| 161 | interpositioned | 1 |
| 162 | interviwed | 1 |
| 163 | leukorrea | 1 |
| 164 | materialised | 1 |
| 165 | mentioned/reported | 1 |
| 166 | near-finalized | 1 |
| 167 | normocytic-normochromic | 1 |
| 168 | perceptually-grounded | 1 |
| 169 | persecuted | 1 |
| 170 | rapidprogress | 1 |
| 171 | re-launched | 1 |
| 172 | recompensed | 1 |
| 173 | reconducted | 1 |
| 174 | relaunched | 1 |
| 175 | republished | 1 |
| 176 | retilted | 1 |
| 177 | rs244072 | 1 |
| 178 | soft/atheromatous | 1 |
| 179 | under-acknowledged | 1 |
| 180 | white-red | 1 |
| 181 | £1919.64 | 1 |
| 182 | £424.56 | 1 |
| 183 | £8642 | 1 |
| 184 | £9085 | 1 |
| 185 | ¥151 | 1 |
| 186 | €6,045 | 1 |
| 187 | ≤2.0cm | 1 |
| 1 | -0.05+/-0.41 | 1 |
| 2 | -12/+4 | 1 |
| 3 | -17.76 | 1 |
| 4 | -29.36+/-3.68mv | 1 |
| 5 | -5.1±5.6 | 1 |
| 6 | -8.3±1.0 | 1 |
| 7 | .1/1000 | 1 |
| 8 | 0.008μm | 1 |
| 9 | 0.150ng/ml | 1 |
| 10 | 0.23±0.22 | 1 |
| 11 | 0.29±0.26 | 1 |
| 12 | 0.42±0.99 | 1 |
| 13 | 0.49-1.73 | 1 |
| 14 | 0.56°c | 1 |
| 15 | 0.69+/-0.13 | 1 |
| 16 | 0.703+/-0.06 | 1 |
| 17 | 0.71μg/kg/hr | 1 |
| 18 | 0.726-/+0.061 | 1 |
| 19 | 1.10+/-0.87 | 1 |
| 20 | 1.1±1 | 1 |
| 21 | 1.3±3.15 | 1 |
| 22 | 1.4g/l | 1 |
| 23 | 1.50±0.81 | 1 |
| 24 | 1.52±0.7 | 1 |
| 25 | 1.72±1.34 | 1 |
| 26 | 1.7±1.53u | 1 |
| 27 | 1.8±1.3 | 1 |
| 28 | 1/1475 | 1 |
| 29 | 10+/-0 | 1 |
| 30 | 10.3±5.2 | 1 |
| 31 | 10.6° | 1 |
| 32 | 10.7months | 1 |
| 33 | 100:55 | 1 |
| 34 | 11.2±3.1 | 1 |
| 35 | 11.6+/-17 | 1 |
| 36 | 11.6° | 1 |
| 37 | 112.55° | 1 |
| 38 | 12+/-2.5 | 1 |
| 39 | 12.3+/-12.4 | 1 |
| 40 | 123.56+/-4.8 | 1 |
| 41 | 123° | 1 |
| 42 | 126.0months | 1 |
| 43 | 126.3° | 1 |
| 44 | 139.9±92 | 1 |
| 45 | 15-ketopge1 | 1 |
| 46 | 15.67±2.3 | 1 |
| 47 | 15.7±9 | 1 |
| 48 | 1596+/-362 | 1 |
| 49 | 16+/-7 | 1 |
| 50 | 16.4+/-7 | 1 |
| 51 | 166.1±65.49ml | 1 |
| 52 | 166/100,000 | 1 |
| 53 | 18:17 | 1 |
| 54 | 1:0.79 | 1 |
| 55 | 1:19,939 | 1 |
| 56 | 2.27±0.84mm | 1 |
| 57 | 2.2±1.4 | 1 |
| 58 | 2.38/10 | 1 |
| 59 | 2.44±0.88 | 1 |
| 60 | 2.54±2.34 | 1 |
| 61 | 2.72:1 | 1 |
| 62 | 2.95g/kg | 1 |
| 63 | 21.4s | 1 |
| 64 | 21.6232 | 1 |
| 65 | 216s | 1 |
| 66 | 22.26° | 1 |
| 67 | 230.57/1000 | 1 |
| 68 | 24/1000 | 1 |
| 69 | 27.5/59.1 | 1 |
| 70 | 27.56±4.20 | 1 |
| 71 | 2778.5 | 1 |
| 72 | 28-29°c | 1 |
| 73 | 29.2/28.7 | 1 |
| 74 | 29.2mg/day | 1 |
| 75 | 3.09±1.12 | 1 |
| 76 | 3.10±0.16 | 1 |
| 77 | 3.3±2.0 | 1 |
| 78 | 3.5±1.4msv | 1 |
| 79 | 3.75d | 1 |
| 80 | 30.32+/-25.97 | 1 |
| 81 | 322.5 | 1 |
| 82 | 33.6±11.9 | 1 |
| 83 | 34.68±30.75min | 1 |
| 84 | 36.7° | 1 |
| 85 | 3638rmb | 1 |
| 86 | 39,960 | 1 |
| 87 | 39.3/76.6 | 1 |
| 88 | 4.0/1,000 | 1 |
| 89 | 4.17+/-2.03 | 1 |
| 90 | 4.40mg/g | 1 |
| 91 | 4.90±2.07 | 1 |
| 92 | 40.7±8 | 1 |
| 93 | 42.9+/-2.8 | 1 |
| 94 | 43.9° | 1 |
| 95 | 4±3 | 1 |
| 96 | 5,453,441 | 1 |
| 97 | 5,588 | 1 |
| 98 | 5.0days | 1 |
| 99 | 5.1±1.88 | 1 |
| 100 | 5.58° | 1 |
| 101 | 5.8_0.26 | 1 |
| 102 | 5.9±2.2 | 1 |
| 103 | 530.83±43.48 | 1 |
| 104 | 590±506ng/ml | 1 |
| 105 | 6.1±10.98 | 1 |
| 106 | 6.72±0.99 | 1 |
| 107 | 63.4±7.8 | 1 |
| 108 | 75.6±11.0 | 1 |
| 109 | 78.3/228.3 | 1 |
| 110 | 8.05±0.43 | 1 |
| 111 | 8.07g/dl | 1 |
| 112 | 8.4+/-2.3 | 1 |
| 113 | 8.7/10 | 1 |
| 114 | 80.7° | 1 |
| 115 | 84.000 | 1 |
| 116 | 84.75+/-10.2 | 1 |
| 117 | 84.8±45.6 | 1 |
| 118 | 9.64min | 1 |
| 119 | 9.8/1000 | 1 |
| 120 | 91.4±27.7s | 1 |
| 121 | 92days | 1 |
| 122 | 95/100,000 | 1 |
| 123 | 98.6±9.8s | 1 |
| 124 | 99+/-22 | 1 |
| 125 | accomrease | 1 |
| 126 | achieved/maintained | 1 |
| 127 | added/intensified | 1 |
| 128 | administerd | 1 |
| 129 | antero-superior | 1 |
| 130 | applied.rebleeding | 1 |
| 131 | arised | 9 |
| 132 | coinfused | 8 |
| 133 | colo-vesical | 1 |
| 134 | comducted | 1 |
| 135 | corticosteroid-insensitive | 1 |
| 136 | cost-additive | 1 |
| 137 | d=0.416 | 1 |
| 138 | decarboxylized | 1 |
| 139 | deorphanized | 1 |
| 140 | diagnosticated | 1 |
| 141 | disscused | 1 |
| 142 | effectiveless | 2 |
| 143 | embolised | 1 |
| 144 | erradicated | 1 |
| 145 | evlauated | 1 |
| 146 | gastro-enteropancreatic | 1 |
| 147 | good-excellent | 2 |
| 148 | goserelin.for | 1 |
| 149 | grade≤3 | 1 |
| 150 | hpa-1a | 1 |
| 151 | humoral-pathological | 1 |
| 152 | hyperexpressed | 1 |
| 153 | hyposynchronization | 1 |
| 154 | immunoexpressed | 2 |
| 155 | indefinable | 1 |
| 156 | inproved | 1 |
| 157 | interpositioned | 1 |
| 158 | interviwed | 1 |
| 159 | leukorrea | 1 |
| 160 | materialised | 1 |
| 161 | mentioned/reported | 1 |
| 162 | morcellated | 2 |
| 163 | near-finalized | 1 |
| 164 | normocytic-normochromic | 1 |
| 165 | perceptually-grounded | 1 |
| 166 | persecuted | 1 |
| 167 | postpolymerized | 3 |
| 168 | rapidprogress | 1 |
| 169 | re-launched | 1 |
| 170 | recompensed | 1 |
| 171 | reconducted | 1 |
| 172 | relaunched | 1 |
| 173 | republished | 1 |
| 174 | retilted | 1 |
| 175 | rs244072 | 1 |
| 176 | seen | 15,700 |
| 177 | soft/atheromatous | 1 |
| 178 | under-acknowledged | 1 |
| 179 | well-represented | 3 |
| 180 | white-red | 1 |
| 181 | £1919.64 | 1 |
| 182 | £424.56 | 1 |
| 183 | £8642 | 1 |
| 184 | £9085 | 1 |
| 185 | ¥151 | 1 |
| 186 | €6,045 | 1 |
| 187 | ≤2.0cm | 1 |
| 1 | 10+/-0 | 1 |
| 2 | 75.6±11.0 | 1 |
| 3 | -8.3±1.0 | 1 |
| 4 | 3.3±2.0 | 1 |
| 5 | 95/100,000 | 1 |
| 6 | 166/100,000 | 1 |
| 7 | 4.0/1,000 | 1 |
| 8 | 84.000 | 1 |
| 9 | .1/1000 | 1 |
| 10 | 24/1000 | 1 |
| 11 | 230.57/1000 | 1 |
| 12 | 9.8/1000 | 1 |
| 13 | 8.7/10 | 1 |
| 14 | 2.38/10 | 1 |
| 15 | 27.56±4.20 | 1 |
| 16 | 39,960 | 1 |
| 17 | 11.2±3.1 | 1 |
| 18 | 27.5/59.1 | 1 |
| 19 | -0.05+/-0.41 | 1 |
| 20 | 5,453,441 | 1 |
| 21 | ¥151 | 1 |
| 22 | 0.726-/+0.061 | 1 |
| 23 | 1.50±0.81 | 1 |
| 24 | 2.72:1 | 1 |
| 25 | 15-ketopge1 | 1 |
| 26 | 1.1±1 | 1 |
| 27 | 84.75+/-10.2 | 1 |
| 28 | 5.9±2.2 | 1 |
| 29 | 10.3±5.2 | 1 |
| 30 | 3.09±1.12 | 1 |
| 31 | 99+/-22 | 1 |
| 32 | 0.23±0.22 | 1 |
| 33 | 21.6232 | 1 |
| 34 | £8642 | 1 |
| 35 | 1596+/-362 | 1 |
| 36 | rs244072 | 1 |
| 37 | 139.9±92 | 1 |
| 38 | 1.8±1.3 | 1 |
| 39 | 8.4+/-2.3 | 1 |
| 40 | 15.67±2.3 | 1 |
| 41 | 78.3/228.3 | 1 |
| 42 | 4.17+/-2.03 | 1 |
| 43 | 0.69+/-0.13 | 1 |
| 44 | 8.05±0.43 | 1 |
| 45 | 0.49-1.73 | 1 |
| 46 | grade≤3 | 1 |
| 47 | 4±3 | 1 |
| 48 | -12/+4 | 1 |
| 49 | 2.2±1.4 | 1 |
| 50 | 12.3+/-12.4 | 1 |
| 51 | 1.72±1.34 | 1 |
| 52 | 2.54±2.34 | 1 |
| 53 | £1919.64 | 1 |
| 54 | 12+/-2.5 | 1 |
| 55 | 322.5 | 1 |
| 56 | 2778.5 | 1 |
| 57 | 1.3±3.15 | 1 |
| 58 | €6,045 | 1 |
| 59 | 100:55 | 1 |
| 60 | 1/1475 | 1 |
| 61 | £9085 | 1 |
| 62 | 84.8±45.6 | 1 |
| 63 | -5.1±5.6 | 1 |
| 64 | 39.3/76.6 | 1 |
| 65 | 0.703+/-0.06 | 1 |
| 66 | 3.10±0.16 | 1 |
| 67 | d=0.416 | 1 |
| 68 | 5.8_0.26 | 1 |
| 69 | 0.29±0.26 | 1 |
| 70 | £424.56 | 1 |
| 71 | -17.76 | 1 |
| 72 | 16.4+/-7 | 1 |
| 73 | 16+/-7 | 1 |
| 74 | 1.52±0.7 | 1 |
| 75 | 29.2/28.7 | 1 |
| 76 | 4.90±2.07 | 1 |
| 77 | 11.6+/-17 | 1 |
| 78 | 18:17 | 1 |
| 79 | 1.10+/-0.87 | 1 |
| 80 | 30.32+/-25.97 | 1 |
| 81 | 42.9+/-2.8 | 1 |
| 82 | 123.56+/-4.8 | 1 |
| 83 | 63.4±7.8 | 1 |
| 84 | 530.83±43.48 | 1 |
| 85 | 2.44±0.88 | 1 |
| 86 | 5.1±1.88 | 1 |
| 87 | 5,588 | 1 |
| 88 | 6.1±10.98 | 1 |
| 89 | 40.7±8 | 1 |
| 90 | 33.6±11.9 | 1 |
| 91 | 1:19,939 | 1 |
| 92 | 1:0.79 | 1 |
| 93 | 0.42±0.99 | 1 |
| 94 | 6.72±0.99 | 1 |
| 95 | 15.7±9 | 1 |
| 96 | hpa-1a | 1 |
| 97 | leukorrea | 1 |
| 98 | 3638rmb | 1 |
| 99 | normocytic-normochromic | 1 |
| 100 | gastro-enteropancreatic | 1 |
| 101 | 0.56°c | 1 |
| 102 | 28-29°c | 1 |
| 103 | 3.75d | 1 |
| 104 | perceptually-grounded | 1 |
| 105 | under-acknowledged | 1 |
| 106 | re-launched | 1 |
| 107 | relaunched | 1 |
| 108 | republished | 1 |
| 109 | added/intensified | 1 |
| 110 | achieved/maintained | 1 |
| 111 | interpositioned | 1 |
| 112 | white-red | 1 |
| 113 | materialised | 1 |
| 114 | embolised | 1 |
| 115 | arised | 9 |
| 116 | recompensed | 1 |
| 117 | immunoexpressed | 2 |
| 118 | hyperexpressed | 1 |
| 119 | disscused | 1 |
| 120 | coinfused | 8 |
| 121 | erradicated | 1 |
| 122 | diagnosticated | 1 |
| 123 | morcellated | 2 |
| 124 | evlauated | 1 |
| 125 | comducted | 1 |
| 126 | reconducted | 1 |
| 127 | retilted | 1 |
| 128 | well-represented | 3 |
| 129 | mentioned/reported | 1 |
| 130 | persecuted | 1 |
| 131 | inproved | 1 |
| 132 | interviwed | 1 |
| 133 | near-finalized | 1 |
| 134 | decarboxylized | 1 |
| 135 | deorphanized | 1 |
| 136 | postpolymerized | 3 |
| 137 | administerd | 1 |
| 138 | indefinable | 1 |
| 139 | accomrease | 1 |
| 140 | cost-additive | 1 |
| 141 | corticosteroid-insensitive | 1 |
| 142 | 4.40mg/g | 1 |
| 143 | 2.95g/kg | 1 |
| 144 | applied.rebleeding | 1 |
| 145 | 1.4g/l | 1 |
| 146 | humoral-pathological | 1 |
| 147 | colo-vesical | 1 |
| 148 | 8.07g/dl | 1 |
| 149 | 0.150ng/ml | 1 |
| 150 | 590±506ng/ml | 1 |
| 151 | 166.1±65.49ml | 1 |
| 152 | ≤2.0cm | 1 |
| 153 | 2.27±0.84mm | 1 |
| 154 | 0.008μm | 1 |
| 155 | seen | 15,700 |
| 156 | 9.64min | 1 |
| 157 | 34.68±30.75min | 1 |
| 158 | hyposynchronization | 1 |
| 159 | 0.71μg/kg/hr | 1 |
| 160 | goserelin.for | 1 |
| 161 | antero-superior | 1 |
| 162 | 21.4s | 1 |
| 163 | 216s | 1 |
| 164 | 91.4±27.7s | 1 |
| 165 | 98.6±9.8s | 1 |
| 166 | 126.0months | 1 |
| 167 | 10.7months | 1 |
| 168 | effectiveless | 2 |
| 169 | rapidprogress | 1 |
| 170 | soft/atheromatous | 1 |
| 171 | 5.0days | 1 |
| 172 | 92days | 1 |
| 173 | good-excellent | 2 |
| 174 | 1.7±1.53u | 1 |
| 175 | -29.36+/-3.68mv | 1 |
| 176 | 3.5±1.4msv | 1 |
| 177 | 29.2mg/day | 1 |
| 178 | 126.3° | 1 |
| 179 | 123° | 1 |
| 180 | 112.55° | 1 |
| 181 | 10.6° | 1 |
| 182 | 11.6° | 1 |
| 183 | 22.26° | 1 |
| 184 | 80.7° | 1 |
| 185 | 36.7° | 1 |
| 186 | 5.58° | 1 |
| 187 | 43.9° | 1 |